.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
US Army
Daiichi Sankyo
Chubb
Colorcon
Queensland Health
Healthtrust
AstraZeneca
Citi
UBS

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203505

« Back to Dashboard

NDA 203505 describes OSPHENA, which is a drug marketed by Duchesnay and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug. Additional details are available on the OSPHENA profile page.

The generic ingredient in OSPHENA is ospemifene. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ospemifene profile page.

Summary for 203505

Tradename:1
Applicant:1
Ingredient:1
Patents:7
Formulation / Manufacturing:see details

Pharmacology for NDA: 203505

Suppliers and Packaging for NDA: 203505

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OSPHENA ospemifene TABLET;ORAL 203505 NDA Shionogi Inc. 59630-580 59630-580-90 90 TABLET, FILM COATED in 1 BOTTLE (59630-580-90)
OSPHENA ospemifene TABLET;ORAL 203505 NDA Shionogi Inc. 59630-580 59630-580-18 1 BLISTER PACK in 1 PACKAGE (59630-580-18) > 15 TABLET, FILM COATED in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength60MG
Approval Date:Feb 26, 2013TE:RLD:Yes
Regulatory Exclusivity Expiration:Feb 26, 2018
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Patent:► SubscribePatent Expiration:Jul 21, 2020Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF DYSPAREUNIA ASSOCIATED WITH MENOPAUSE
Patent:► SubscribePatent Expiration:Aug 11, 2026Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF DYSPAREUNIA ASSOCIATED WITH MENOPAUSE


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Federal Trade Commission
Teva
Farmers Insurance
UBS
Queensland Health
Healthtrust
Julphar
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot